Immunoassay Double Cut-Off Curve Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing antibody detection assays face challenges in achieving high specificity and sensitivity due to variations in antibody amounts among individuals, leading to high false positive and false negative results, particularly in diseases like lung cancer where the incidence is low.
Innovation Solution
The method involves assessing both the amount of antigen/antibody binding and a secondary curve parameter, using a 'double cut-off' approach, which requires plotting specific binding curves and calculating parameters like Slope, Intercept, Area Under the Curve, and dissociation constant to determine antibody presence, thereby increasing assay specificity and sensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If a single cut-off threshold is used for antibody detection, then the assay is simple to operate, but the false positive rate increases and specificity decreases
Solution Approach 1:
The patent transitions from a single-dimensional threshold comparison to a two-dimensional evaluation system by introducing the secondary curve parameter (slope or curvature) in addition to the primary binding amount. This dimensional expansion allows differentiation between true positives and false positives that would otherwise be indistinguishable using a single cut-off value, thereby resolving the contradiction between operational simplicity and assay reliability.
Solution Approach 2:
The patent changes the evaluation parameters from a single binding amount metric to multiple parameters including the primary binding amount and a secondary curve parameter (slope or curvature). This parameter expansion enables more nuanced discrimination of antibody presence while maintaining a systematic evaluation framework that balances complexity and reliability.
2Measurement precision
If multiple antigens are used simultaneously to improve sensitivity, then the detection capability increases, but the false positive rate increases and specificity decreases
Solution Approach 1:
The patent applies the two-dimensional evaluation system (primary binding amount + secondary curve parameter) to each antigen individually and in combination. This allows the assay to leverage multiple antigens for improved sensitivity while using the secondary parameter to filter out false positives that may arise from non-specific reactivity with any single antigen, thus maintaining high specificity despite multi-antigen complexity.
Solution Approach 2:
The secondary curve parameter serves as a universal filter across all antigens tested. Whether one or multiple antigens are used, the same secondary parameter evaluation methodology applies, providing a consistent mechanism to distinguish specific from non-specific binding regardless of the number of antigens involved, thereby maintaining specificity while allowing sensitivity enhancement through multi-antigen approaches.
3Reliability
If antigen titration with curve plotting is performed, then the false positive rate decreases and specificity increases, but the assay complexity and time required increase
Solution Approach 1:
The patent extracts only the essential features from full antigen titration curve analysis - specifically the secondary parameter (slope or curvature) - while discarding the need for complete curve plotting and extensive data analysis. This extraction approach retains the specificity-enhancing benefits of titration-based evaluation while eliminating the procedural complexity and time requirements of traditional curve plotting methods.
Solution Approach 2:
The patent performs a partial form of antigen titration by evaluating binding at multiple antigen concentrations but focusing analysis on the secondary curve parameter rather than requiring complete curve characterization. This partial action approach achieves the specificity benefits of titration without the full complexity of traditional curve plotting and analysis protocols.
4Reliability
If antigen titration is performed to reduce false positives, then the Positive Predictive Value increases, but the time and resources required for the assay increase
Solution Approach 1:
The patent extracts only the critical secondary parameter (slope or curvature) from full antigen titration analysis, eliminating the need for complete curve plotting and extensive data processing. This extraction maintains the Positive Predictive Value enhancement benefits while dramatically reducing the time and computational resources required compared to traditional titration-based approaches.
Solution Approach 2:
The patent implements a streamlined version of antigen titration that evaluates binding across multiple concentrations but focuses measurement and analysis on the secondary curve parameter. This partial action approach achieves high Positive Predictive Value without requiring the full time investment and resource allocation of complete titration curve analysis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces false positive results, enhances the Positive Predictive Value (PPV), and allows for the use of multiple antigens simultaneously, improving assay sensitivity without compromising specificity, thus providing a more reliable diagnostic tool for diseases like lung cancer.
Implementation Method 1
contacting said test sample with a plurality of different amounts of an antigen specific for said antibody; detecting the amount of specific binding between said antibody and said antigen
Data Source
Figure 1A
Figure 1B
Figure 2
AI summary
The present invention generally relates to the field of antibody detection, and in particular relates to assays for the detection of antibodies in a sample comprising patient bodily fluid. The invention provides a method of detecting an antibody in a test sample comprising a bodily fluid from a mammalian subject, wherein the test sample is contacted with a plurality of different amounts of an antigen specific for the antibody, the amount of specific binding between the antibody and the antigen is detected and the presence or absence of antibody is determined based upon the amount of specific binding between the antibody and the antigen and a secondary curve parameter arising from a curve of the amount of specific binding versus the amount of antigen for each amount of antigen used.